Your browser doesn't support javascript.
loading
Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury.
Szelid, Zsolt; Pokreisz, Peter; Liu, Xiaoshun; Vermeersch, Pieter; Marsboom, Glenn; Gillijns, Hilde; Pellens, Marijke; Verbeken, Erik; Van de Werf, Frans; Collen, Desire; Janssens, Stefan P.
Afiliación
  • Szelid Z; Vesalius Research Center, Flanders Institute for Biotechnology (VIB), Leuven, Belgium.
Basic Res Cardiol ; 105(2): 169-79, 2010 Mar.
Article en En | MEDLINE | ID: mdl-20020305
Nitric oxide modulates the severity of myocardial ischemia-reperfusion (I/R) injury. We investigated whether cardioselective nitric oxide synthase 3 (NOS3) gene transfer could confer myocardial protection against I/R injury in pigs and examined potential molecular mechanisms. I/R injury was induced by balloon occlusion of the left anterior descending artery for 45 min followed by 4 or 72 h reperfusion. Hemodynamic and pathological changes were measured in pigs in the absence (n = 11) or presence of prior intracoronary retroinfusion of human NOS3 (AdNOS3, 5 x 10(10) PFU, n = 13) or control vector (AdRR5, 5 x 10(10) PFU, n = 11). Retrograde NOS3 gene transfer selectively increased NOS3 expression and NO bioavailability in the area at risk (AAR) without changing endogenous NOS isoform expression. At 4 h R, LV systolic (dP/dt(max)) and diastolic (dP/dt(min)) function was better preserved in AdNOS3- than in AdRR5-injected pigs (2,539 +/- 165 vs. 1,829 +/- 156 mmHg/s, and -2,781 +/- 340 vs. -2,062 +/- 292 mmHg/s, respectively, P < 0.05 for both). Myocardial infarct size (% AAR) was significantly smaller in AdNOS3 than in control and AdRR5 and associated with a significantly greater reduction in cardiac myeloperoxidase activity, a marker of neutrophil infiltration. The latter effects were sustained at 72 h R in a subset of pigs (n = 7). In the AAR, intercellular endothelial adhesion molecule-1 expression and cardiomyocyte apoptosis were significantly lower in AdNOS3. In conclusion, single myocardial NOS3 retroinfusion attenuates I/R injury, and causes a sustained reduction in myocardial infarct size and inflammatory cell infiltration. Gene-based strategies to increase NO bioavailability may have therapeutic potential in myocardial I/R.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Daño por Reperfusión Miocárdica / Óxido Nítrico Sintasa de Tipo III Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Basic Res Cardiol Año: 2010 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Daño por Reperfusión Miocárdica / Óxido Nítrico Sintasa de Tipo III Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: Basic Res Cardiol Año: 2010 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Alemania